Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer

被引:0
|
作者
Capuozzo, Maurizio [1 ]
Santorsola, Mariachiara [2 ]
Ianniello, Monica [3 ]
Ferrara, Francesco [1 ]
Zovi, Andrea [4 ]
Petrillo, Nadia [3 ]
Castiello, Rosa [3 ]
Fantuz, Maria Rosaria [3 ]
Ottaiano, Alessandro [2 ]
Savarese, Giovanni [3 ]
机构
[1] ASL Naples 3, Coordinamento Farmaceut, I-80056 Ercolano, Italy
[2] IRCCS G Pascale, Ist Nazl Tumori Napoli, Via M Semmola, I-80131 Naples, Italy
[3] Ctr Polidiagnost Strumentale Srl, AMES, Via Padre Carmine Fico 24, I-80013 Casalnuovo Di Napoli, Italy
[4] Minist Hlth, Viale Giorgio Ribotta 5, I-00144 Rome, Italy
关键词
prostate cancer; androgen-deprivation therapy; immunotherapy; PARP inhibitors; precision medicine; PHASE-III TRIAL; SIPULEUCEL-T; DOUBLE-BLIND; PLUS STANDARD; OPEN-LABEL; CASTRATION; IPILIMUMAB; IMMUNOTHERAPY; ENZALUTAMIDE; MULTICENTER;
D O I
10.3390/diseases12050087
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Prostate cancer, a prevalent malignancy affecting the prostate gland, is a significant global health concern. Androgen-deprivation therapy (ADT) has proven effective in controlling advanced disease, with over 50% of patients surviving at the 10-year mark. However, a diverse spectrum of responses exists, and resistance to ADT may emerge over time. This underscores the need to explore innovative treatment strategies for effectively managing prostate cancer progression. Ongoing research endeavors persist in unraveling the complexity of prostate cancer and fostering the development of biologic and innovative approaches, including immunotherapies and targeted therapies. This review aims to provide a valuable synthesis of the dynamic landscape of emerging drug modalities in this context. Interestingly, the complexities posed by prostate cancer not only present a formidable challenge but also serve as a model and an opportunity for translational research and innovative therapies in the field of oncology.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Drug design strategies for the treatment of prostate cancer
    Lauer, Richard C.
    Friend, Sarah C.
    Rietz, Cecilia
    Pasqualini, Renata
    Arap, Wadih
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (01) : 81 - 90
  • [2] Management of Advanced Prostate Cancer in the Precision Oncology Era
    Gillette, Claire M. M.
    Yette, Gabriel A. A.
    Cramer, Scott D. D.
    Graham, Laura S. S.
    CANCERS, 2023, 15 (09)
  • [3] Emerging treatment options for prostate cancer
    Atiq, Mohammad
    Chandran, Elias
    Karzai, Fatima
    Madan, Ravi A.
    Aragon-Ching, Jeanny B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (06) : 625 - 631
  • [4] Combining immunotherapies for the treatment of prostate cancer
    Redman, Jason M.
    Gulley, James L.
    Madan, Ravi A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (12) : 694 - 700
  • [5] Prostate cancer vaccines in combination with additional treatment modalities
    Uhlman, Matthew A.
    Bing, Megan T.
    Lubaroff, David M.
    IMMUNOLOGIC RESEARCH, 2014, 59 (1-3) : 236 - 242
  • [6] Progression in immunotherapy for advanced prostate cancer
    Liang, Hao
    Liu, Yang
    Guo, Jiao
    Dou, Maoyang
    Zhang, Xiaoyi
    Hu, Liyong
    Chen, Jun
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] The evolving landscape of immunotherapy in advanced prostate cancer
    Patel, Vaibhav G.
    Oh, William K.
    IMMUNOTHERAPY, 2019, 11 (10) : 903 - 912
  • [8] A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
    Sooi, Kenneth
    Walsh, Robert
    Kumarakulasinghe, Nesaretnam
    Wong, Alvin
    Ngoi, Natalie
    CANCER DRUG RESISTANCE, 2023, 6 (03) : 656 - 673
  • [9] Recent Advances in Mesothelioma Treatment: Immunotherapy, Advanced Cell Therapy, and Other Innovative Therapeutic Modalities
    Suraya, Ratoe
    Nagano, Tatsuya
    Tachihara, Motoko
    CANCERS, 2025, 17 (04)
  • [10] Treatment of Advanced Prostate Cancer
    Teo, Min Yuen
    Rathkopf, Dana E.
    Kantoff, Philip
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 479 - 499